Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China flag China · Delayed Price · Currency is CNY
16.14
-0.98 (-5.72%)
Nov 17, 2026, 3:00 PM CST

SHA:688393 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
39.6731.2795.1567.6890.91217.68
Trading Asset Securities
257.98234.3655.3352.56175.54419.42
Cash & Short-Term Investments
297.65265.63150.48120.25266.45637.1
Cash Growth
12.67%76.52%25.14%-54.87%-58.18%-24.67%
Accounts Receivable
156.23179.52242.84245.25239.03211.94
Other Receivables
2.992.244.374.264.194.06
Receivables
159.23181.76247.21249.51243.22216.01
Inventory
113.8890.1284.4474.9763.0740.57
Prepaid Expenses
-0.352.541.932.123.99
Other Current Assets
9.9474.26207.58120.9220.2211.51
Total Current Assets
580.69612.13692.25567.57595.08909.17
Property, Plant & Equipment
220.08238.32298.53314.38327.04276.65
Long-Term Investments
253.21263.93241.91402.48373.5286.07
Goodwill
26.1826.1826.4626.4629.5229.52
Other Intangible Assets
31.3610.65.586.475.785.85
Long-Term Deferred Tax Assets
49.7245.7735.6327.6119.0412.69
Long-Term Deferred Charges
23.8137.4940.5532.3715.754.17
Other Long-Term Assets
50.7552.9821.8122.5927.0641.56
Total Assets
1,2361,2871,3631,4001,3931,366

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
35.7633.7332.6837.1432.5949.76
Accrued Expenses
11.8231.6829.3930.6334.3128.14
Short-Term Debt
-0.157.321.214.37
Current Portion of Leases
1.792.071.4923.262.54
Current Income Taxes Payable
6.531.470.883.022.12.11
Current Unearned Revenue
11.517.76.326.8212.728.32
Other Current Liabilities
7.56.566.449.5214.998.97
Total Current Liabilities
74.9183.3784.51110.33114.26106.84
Long-Term Leases
0.50.881.655.187.242.85
Long-Term Unearned Revenue
28.9726.9427.5428.1928.9429.89
Long-Term Deferred Tax Liabilities
14.215.1513.371416.0813.34
Other Long-Term Liabilities
1.31.653.923.923.923.04
Total Liabilities
119.87127.98130.99161.63170.45155.96

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
93.5793.5793.5793.5793.3493.34
Additional Paid-In Capital
680.47718.78734.14749.14741.35733.87
Retained Earnings
363.72371.78428.16420.9394.29376.79
Comprehensive Income & Other
-13.35-0.16-0.12--0.38-
Total Common Equity
1,1241,1841,2561,2641,2291,204
Minority Interest
-8.48-24.53-24-25.31-6.275.72
Shareholders' Equity
1,1161,1591,2321,2381,2221,210
Total Liabilities & Equity
1,2361,2871,3631,4001,3931,366

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2.283.110.4428.3924.812.39
Net Cash (Debt)
295.37262.53140.0491.86241.64624.71
Net Cash Growth
18.20%87.46%52.45%-61.99%-61.32%-26.13%
Net Cash Per Share
2.372.791.510.962.556.66
Filing Date Shares Outstanding
93.5793.5793.5793.5793.3493.34
Total Common Shares Outstanding
93.5793.5793.5793.5793.3493.34
Working Capital
505.78528.76607.74457.23480.81802.34
Book Value Per Share
12.0212.6513.4213.5013.1612.90
Tangible Book Value
1,0671,1471,2241,2311,1931,169
Tangible Book Value Per Share
11.4012.2613.0813.1512.7812.52
Buildings
-216.09256.64256.58238.97216.44
Machinery
-173.88168.4151.86141.86116.01
Construction In Progress
--0.740.1910.5610.99